Immediate Impact

6 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
2024 Standout
9 intermediate papers

Works of Eli V. Gelfand being referenced

Severity of Mitral and Aortic Regurgitation as Assessed by Cardiovascular Magnetic Resonance: Optimizing Correlation with Doppler Echocardiography
2006
Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors
2006

Author Peers

Author Last Decade Papers Cites
Eli V. Gelfand 440 184 147 148 33 658
Amitoj Singh 240 62 143 134 48 679
Nobuaki Kokubu 507 206 197 107 43 769
Ali Elitok 394 112 142 144 46 737
Ruiqi Zhang 399 96 168 79 27 832
W. Waas 363 110 186 59 28 672
Mahmoud M. Ramadan 408 46 149 99 44 672
Amber Fatima 485 87 154 59 22 633
Dimitrios T. Karamitsos 308 48 203 124 29 847
Joel Estis 315 59 70 97 39 676
Niels C. F. Sandgaard 378 45 77 93 29 661

All Works

Loading papers...

Rankless by CCL
2026